SELENBP1 and in situ carcinoma: Twenty-nine cancer samples and 30 margin samples were collected from patients undergoing surgical ablation of Larynx squamous cell carcinoma, the relative expression of SELENBP1 gene was lower in beginning and advance of tumor stage than in margin (P < 0.01) (Fig. 1C).